UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

The lancet oncology, 2013-03, Vol.14 (3), p.199-209

2013

Volltextzugriff (PDF)

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

The lancet oncology, 2014-07, Vol.15 (8), p.809-818

2014

Volltextzugriff (PDF)

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials

Haematologica (Roma), 2022-09, Vol.107 (9), p.2051

2022

Volltextzugriff (PDF)

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

Journal of clinical oncology, 2022-12, Vol.40 (36), p.4228-4239

2022

Volltextzugriff (PDF)

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

Leukemia, 2022-03, Vol.36 (3), p.625-636

2022

Volltextzugriff (PDF)

Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia

HemaSphere, 2024-06, Vol.8 (6), p.e88-n/a

2024

Volltextzugriff (PDF)

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

The Lancet. Haematology, 2022-04, Vol.9 (4), p.e276-e288

2022

Volltextzugriff (PDF)

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-02, Vol.27 (5), p.763-769

2009

Volltextzugriff (PDF)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis

Health economics review, 2019-12, Vol.9 (40), p.1-13, Article 40

2019

Volltextzugriff (PDF)

Management of adults with T-cell lymphoblastic leukemia

Blood, 2017-03, Vol.129 (9), p.1134-1142

2017

Volltextzugriff (PDF)

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

Blood advances, 2021-09, Vol.5 (17), p.3322-3332

2021

Volltextzugriff (PDF)

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Clinical cancer research, 2008-12, Vol.14 (24), p.8102-8111

2008

Volltextzugriff (PDF)

Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003

British journal of haematology, 2016-02, Vol.172 (3), p.439-451

2016

Volltextzugriff (PDF)

Outcome for children and young people with Early T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

British journal of haematology, 2014-08, Vol.166 (3), p.421-424

2014

Volltextzugriff (PDF)

Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia

Clinical and experimental nephrology, 2009-04, Vol.13 (2), p.179-181

2009

Volltextzugriff (PDF)

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38

Haematologica (Roma), 2010-03, Vol.95 (3), p.514-517

2010

Volltextzugriff (PDF)

Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T

International journal of hematology, 2023-05, Vol.117 (5), p.765-768

2023

Volltextzugriff (PDF)

High Dose Methotrexate Does Not Reduce the Risk of CNS Relapse in Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma. Results of the Randomised Phase III Study UKALL 2011

Blood, 2022-11, Vol.140 (Supplement 1), p.516-518

2022

Volltextzugriff (PDF)

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Blood, 2019-11, Vol.134 (Supplement_1), p.2579-2579

2019

Volltextzugriff (PDF)

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1328-1337

2018

Volltextzugriff (PDF)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Leukemia, 2020-11, Vol.34 (11), p.3091-3096

2020

Volltextzugriff (PDF)

Final Results from UKALL60+ (NCT01616238), a UK National Cancer Research Institute Trial for Older People with De Novo Acute Lymphoblastic Leukaemia

Blood, 2022-11, Vol.140 (Supplement 1), p.6125-6126

2022

Volltextzugriff (PDF)

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

British journal of haematology, 2020-08, Vol.190 (3), p.394-404

2020

Volltextzugriff (PDF)

First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006)

Blood, 2021-11, Vol.138 (Supplement 1), p.366-366

2021

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(93)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(38)
Hematology
(25)
Male
(21)
Adult
(20)
Female
(20)
Middle Aged
(13)
Oncology
(13)
Adolescent
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Young Adult
(11)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(10)
Aged
(9)
Child
(9)
Patients
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Prognosis
(8)
Acute Lymphoblastic Leukaemia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials

Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: A UK-based cost-utility analysis

Management of adults with T-cell lymphoblastic leukemia

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003

Outcome for children and young people with Early T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003

Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemia

Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38

Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T

High Dose Methotrexate Does Not Reduce the Risk of CNS Relapse in Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma. Results of the Randomised Phase III Study UKALL 2011

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients

Final Results from UKALL60+ (NCT01616238), a UK National Cancer Research Institute Trial for Older People with De Novo Acute Lymphoblastic Leukaemia

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006)

Suchergebnisse filtern